AHCO on Nasdaq
AdaptHealth Corp.
American home health care services company, incorporated in Delaware1
In its 2026 annual report the company says: “AdaptHealth Corp. and subsidiaries is a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services. The Company operates under four reportable segments that align with its product categories: (i) Sleep Health, (ii) Respiratory Health, (iii) Diabetes Health, and (iv) Wellness at Home.”4 It is headquartered in Conshohocken, Pennsylvania.1 Its shares trade on Nasdaq under the symbol AHCO.1
Price unavailable
Last updated Oct 21, 2026.
Overview
Compare with Chemed Corporation, Aveanna Healthcare Holdings, Inc. or Option Care Health, Inc., or pick any stock.
- TickerAHCO on Nasdaq1
- IndustryServices-Home Health Care Services1
- HeadquartersConshohocken, Pennsylvania1
- Incorporated inDE2
- Business address555 East North Lane, Suite 5075, Conshohocken, Pa 194282
- Filer categoryLarge accelerated filer2
See how the biggest companies compare on our leaderboards
AdaptHealth Corp. and subsidiaries ("AdaptHealth" or "the Company") is a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment (“HME”), medical supplies, and related services. The Company operates under four reportable segments that align with its product categories: (i) Sleep Health, (ii) Respiratory Health, (iii) Diabetes Health, and (iv) Wellness at Home. A description of the products and services provided within each of the Company’s four reportable segments is provided below.4 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
2.8%Operating margin5
-2.2%Net margin5
-0.5%Revenue growth, 20255
-4.7%Return on equity5
1.13×Debt to equity5
$219.4MFree cash flow5
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Business segments
Sleep Health brought in 42% of the revenue AdaptHealth Corp. broke down this way in fiscal 2025.
Business segments by year
| Business segments | 2023 | 2024 | 2025 |
|---|---|---|---|
| Sleep Health | $1.3B | $1.3B | $1.4B |
| Respiratory Health | $614.6M | $651.1M | $691.2M |
| Diabetes Health | $660.0M | $614.4M | $592.4M |
| Wellness at Home | $633.9M | $646.2M | $583.1M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue81¢$2.6B
- Other costs17¢$558.3M
- Income tax2¢$50.9M
Out of $3.2B in revenue.5 The company lost money this year.
Where each dollar of operating cash went, fiscal 2025
- Capital spending64¢$382.4M
- Kept or used elsewhere36¢$219.4M
Out of $601.8M of cash from operations.5
Financial statements
Every line of the income statement as filed: the last 3 fiscal years, latest first.5
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net revenue | $3.2B | $3.3B | $3.2B |
| Cost of net revenue | $2.6B | $2.6B | $2.6B |
| General and administrative expenses | $382.3M | $359.2M | $334.6M |
| Depreciation and amortization, excluding patient equipment depreciation | $40.6M | $45.0M | $57.1M |
| Goodwill impairment (note 7) | $128.0M | $13.1M | $830.8M |
| Total costs and expenses | $3.2B | $3.0B | $3.8B |
| Gain on sale of businesses (note 4) | -$32.6M | $0 | $0 |
| Operating income (loss) | $90.9M | $263.7M | -$598.4M |
| Interest expense, net | $105.8M | $126.7M | $130.3M |
| Loss on extinguishment of debt | $0 | $2.3M | $0 |
| Change in fair value of warrant liability (note 13) | $0 | -$4.0M | -$34.5M |
| Other loss, net | $274.0K | $2.8M | $29.6M |
| (Loss) income before income taxes | -$15.2M | $136.0M | -$723.8M |
| Income tax expense (benefit) | $50.9M | $41.2M | -$49.0M |
| Net (loss) income | -$66.0M | $94.8M | -$674.8M |
| Income attributable to noncontrolling interest | $4.8M | $4.4M | $4.1M |
| Net (loss) income attributable to AdaptHealth Corp. | -$70.8M | $90.4M | -$678.9M |
| Weighted average common shares outstanding - basic (in shares) | 135.1M shares | 133.8M shares | 134.2M shares |
| Weighted average common shares outstanding - diluted (in shares) | 135.1M shares | 135.5M shares | 134.4M shares |
| Basic net (loss) income per share (in dollars per share) | -$0.52 | $0.62 | -$5.06 |
| Diluted net (loss) income per share (in dollars per share) | -$0.52 | $0.61 | -$5.31 |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 5 fiscal years (annual) or 5 quarters (quarterly), latest first.5
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-07-31 |
|---|---|---|---|---|---|
| Cash | $106.1M | $109.7M | $77.1M | $46.3M | |
| Accounts receivable | $370.9M | $408.0M | |||
| Inventory | $151.2M | $139.8M | |||
| Prepaid and other current assets | $100.6M | $45.4M | |||
| Assets held for sale | $0 | $52.7M | |||
| Total current assets | $728.9M | $755.8M | |||
| Equipment and other fixed assets, net | $510.0M | $474.6M | |||
| Operating lease right-of-use assets | $112.0M | $106.0M | |||
| Finance lease right-of-use assets | $52.3M | $37.8M | |||
| Goodwill | $2.5B | $2.7B | $2.7B | ||
| Identifiable intangible assets, net | $85.1M | $105.5M | |||
| Deferred tax assets | $267.8M | $314.5M | |||
| Other assets | $19.1M | $17.6M | |||
| Total Assets | $4.3B | $4.5B | |||
| Accounts payable and accrued expenses | $553.7M | $438.0M | |||
| Current portion of long-term debt | $20.3M | $16.2M | |||
| Current portion of operating lease obligations | $30.7M | $29.9M | |||
| Current portion of finance lease obligations | $17.7M | $14.3M | |||
| Contract liabilities | $59.8M | $34.9M | |||
| Other liabilities | $30.1M | $26.5M | |||
| Liabilities held for sale | $0 | $7.0M | |||
| Total current liabilities | $712.4M | $567.0M | |||
| Long-term debt, less current portion | $1.7B | $2.0B | |||
| Operating lease obligations, less current portion | $85.5M | $80.3M | |||
| Finance lease obligations, less current portion | $32.6M | $24.6M | |||
| Other long-term liabilities | $243.8M | $272.0M | |||
| Total Liabilities | $2.8B | $2.9B | |||
| Common Stock, par value of $0.0001 per share, 300,000,000 shares authorized and 135,450,364 and 134,602,317 shares issued and outstanding as of December 31, 2025 and 2024, respectively | $13.0K | $13.0K | |||
| Preferred Stock, par value of $0.0001 per share, 5,000,000 shares authorized; 124,060 shares issued and outstanding as of December 31, 2025 and 2024 | $1.0K | $1.0K | |||
| Treasury stock, at cost (2,935,035 shares as of December 31, 2025 and 2024) | -$25.5M | -$25.5M | |||
| Additional paid-in capital | $2.2B | $2.2B | |||
| Accumulated deficit | -$633.0M | -$562.2M | |||
| Accumulated other comprehensive income | $78.0K | $2.3M | |||
| Total stockholders' equity attributable to AdaptHealth Corp. | $1.5B | $1.6B | |||
| Noncontrolling interest in subsidiary | $7.8M | $7.0M | |||
| Total Stockholders' Equity | $1.5B | $1.6B | $1.5B | $2.2B | |
| Total Liabilities and Stockholders' Equity | $4.3B | $4.5B | |||
| Common Stock, par value (in dollars per share) | $0.00 | $0.00 | |||
| Common Stock, shares authorized (in shares) | 300.0M shares | 300.0M shares | 300.0M shares | ||
| Common Stock, shares issued (in shares) | 135.5M shares | 134.6M shares | |||
| Common Stock, shares outstanding (in shares) | 135.5M shares | 134.6M shares | |||
| Preferred Stock, par value (in dollars per share) | $0.00 | $0.00 | |||
| Preferred Stock, shares authorized (in shares) | 5.0M shares | 5.0M shares | |||
| Preferred Stock, shares issued (in shares) | 124.1K shares | 124.1K shares | |||
| Preferred Stock, shares outstanding (in shares) | 124.1K shares | 124.1K shares | |||
| Treasury stock, at cost (in shares) | 2.9M shares | 2.9M shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-07-31 |
|---|---|---|---|---|---|
| Cash | $106.1M | $109.7M | $77.1M | $46.3M | |
| Accounts receivable | $370.9M | $408.0M | |||
| Inventory | $151.2M | $139.8M | |||
| Prepaid and other current assets | $100.6M | $45.4M | |||
| Assets held for sale | $0 | $52.7M | |||
| Total current assets | $728.9M | $755.8M | |||
| Equipment and other fixed assets, net | $510.0M | $474.6M | |||
| Operating lease right-of-use assets | $112.0M | $106.0M | |||
| Finance lease right-of-use assets | $52.3M | $37.8M | |||
| Goodwill | $2.5B | $2.7B | $2.7B | ||
| Identifiable intangible assets, net | $85.1M | $105.5M | |||
| Deferred tax assets | $267.8M | $314.5M | |||
| Other assets | $19.1M | $17.6M | |||
| Total Assets | $4.3B | $4.5B | |||
| Accounts payable and accrued expenses | $553.7M | $438.0M | |||
| Current portion of long-term debt | $20.3M | $16.2M | |||
| Current portion of operating lease obligations | $30.7M | $29.9M | |||
| Current portion of finance lease obligations | $17.7M | $14.3M | |||
| Contract liabilities | $59.8M | $34.9M | |||
| Other liabilities | $30.1M | $26.5M | |||
| Liabilities held for sale | $0 | $7.0M | |||
| Total current liabilities | $712.4M | $567.0M | |||
| Long-term debt, less current portion | $1.7B | $2.0B | |||
| Operating lease obligations, less current portion | $85.5M | $80.3M | |||
| Finance lease obligations, less current portion | $32.6M | $24.6M | |||
| Other long-term liabilities | $243.8M | $272.0M | |||
| Total Liabilities | $2.8B | $2.9B | |||
| Common Stock, par value of $0.0001 per share, 300,000,000 shares authorized and 135,450,364 and 134,602,317 shares issued and outstanding as of December 31, 2025 and 2024, respectively | $13.0K | $13.0K | |||
| Preferred Stock, par value of $0.0001 per share, 5,000,000 shares authorized; 124,060 shares issued and outstanding as of December 31, 2025 and 2024 | $1.0K | $1.0K | |||
| Treasury stock, at cost (2,935,035 shares as of December 31, 2025 and 2024) | -$25.5M | -$25.5M | |||
| Additional paid-in capital | $2.2B | $2.2B | |||
| Accumulated deficit | -$633.0M | -$562.2M | |||
| Accumulated other comprehensive income | $78.0K | $2.3M | |||
| Total stockholders' equity attributable to AdaptHealth Corp. | $1.5B | $1.6B | |||
| Noncontrolling interest in subsidiary | $7.8M | $7.0M | |||
| Total Stockholders' Equity | $1.5B | $1.6B | $1.5B | $2.2B | |
| Total Liabilities and Stockholders' Equity | $4.3B | $4.5B | |||
| Common Stock, par value (in dollars per share) | $0.00 | $0.00 | |||
| Common Stock, shares authorized (in shares) | 300.0M shares | 300.0M shares | 300.0M shares | ||
| Common Stock, shares issued (in shares) | 135.5M shares | 134.6M shares | |||
| Common Stock, shares outstanding (in shares) | 135.5M shares | 134.6M shares | |||
| Preferred Stock, par value (in dollars per share) | $0.00 | $0.00 | |||
| Preferred Stock, shares authorized (in shares) | 5.0M shares | 5.0M shares | |||
| Preferred Stock, shares issued (in shares) | 124.1K shares | 124.1K shares | |||
| Preferred Stock, shares outstanding (in shares) | 124.1K shares | 124.1K shares | |||
| Treasury stock, at cost (in shares) | 2.9M shares | 2.9M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.5
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net (loss) income | -$66.0M | $94.8M | -$674.8M |
| Depreciation and amortization, including patient equipment depreciation | $381.9M | $365.3M | $382.8M |
| Goodwill impairment | $128.0M | $13.1M | $830.8M |
| Equity-based compensation | $21.9M | $14.9M | $22.5M |
| Change in fair value of warrant liability | $0 | -$4.0M | -$34.5M |
| Reduction in the carrying amount of operating lease right-of-use assets | $31.1M | $32.8M | $31.9M |
| Reduction in the carrying amount of finance lease right-of-use assets | $15.3M | $11.1M | $5.9M |
| Deferred income tax expense (benefit) | $47.2M | $32.0M | -$62.6M |
| Change in fair value of interest rate swaps, net of reclassification adjustment | $0 | -$367.0K | -$1.8M |
| Amortization of deferred financing costs | $5.7M | $5.7M | $5.2M |
| Loss on extinguishment of debt | $0 | $2.3M | $0 |
| Payment of contingent consideration from an acquisition | $0 | -$1.9M | $0 |
| Gain on sale of businesses (note 4) | -$32.6M | $0 | $0 |
| Other | $2.7M | $2.1M | $350.0K |
| Accounts receivable | $31.0M | -$26.2M | -$28.9M |
| Inventory | -$11.5M | -$28.1M | $15.5M |
| Prepaid and other assets | -$61.1M | $27.3M | -$20.3M |
| Operating lease obligations | -$31.1M | -$32.9M | -$32.4M |
| Operating liabilities | $139.3M | $33.8M | $41.0M |
| Net cash provided by operating activities | $601.8M | $541.8M | $480.7M |
| Purchases of equipment and other fixed assets | -$382.4M | -$306.1M | -$337.5M |
| Payments for business acquisitions, net of cash acquired | -$42.4M | -$9.5M | -$19.7M |
| Proceeds from the sale of businesses, net of cash disposed | $120.4M | $0 | $0 |
| Proceeds from the sale of assets | $0 | $5.3M | $0 |
| Payments for cost method investments | $0 | $0 | -$128.0K |
| Receipt of contingent consideration from the sale of assets | $1.2M | $0 | $0 |
| Net cash used in investing activities | -$303.2M | -$310.3M | -$357.3M |
| Repayments on long-term debt and lines of credit | -$250.0M | -$423.5M | -$95.0M |
| Proceeds from borrowings on lines of credit | $0 | $253.5M | $50.0M |
| Repayments of finance lease obligations | -$18.5M | -$9.9M | -$6.8M |
| Payments for shares purchased under share repurchase program | $0 | $0 | -$29.3M |
| Proceeds from the exercise of stock options | $0 | $742.0K | $587.0K |
| Proceeds received in connection with employee stock purchase plan | $1.2M | $999.0K | $2.0M |
| Payments of debt financing costs | -$25.0M | -$1.4M | -$3.2M |
| Payments of debt financing costs | $0 | -$6.4M | $0 |
| Distributions to noncontrolling interests | -$7.0M | -$5.6M | -$2.5M |
| Payments for tax withholdings from vesting of restricted stock units | -$2.7M | -$2.1M | -$5.8M |
| Payments of contingent consideration and deferred purchase price from acquisitions | -$212.0K | -$5.3M | -$2.5M |
| Net cash used in financing activities | -$302.2M | -$198.9M | -$92.5M |
| Net (decrease) increase in cash | -$3.6M | $32.6M | $30.9M |
| Cash paid for interest | $101.2M | $122.1M | $126.2M |
| Cash paid for income taxes, net of refunds | $24.3M | $14.1M | $14.8M |
| Unpaid equipment and other fixed asset purchases at end of period | $65.9M | $56.1M | $35.9M |
| Operating leases | $37.9M | $35.9M | $22.0M |
| Operating lease obligations | -$37.9M | -$35.9M | -$22.0M |
| Write-off of assets subject to operating lease obligations | -$2.6M | -$6.7M | -$14.7M |
| Write-off of operating lease obligations | $2.6M | $6.7M | $14.7M |
| Assets subject to finance lease obligations | $31.4M | $17.9M | $32.1M |
| Finance lease obligations | -$31.4M | -$17.9M | -$32.1M |
| Write-off of assets subject to finance lease obligations | -$1.6M | -$513.0K | $0 |
| Write-off of finance lease obligations | $1.6M | $513.0K | $0 |
| Deferred purchase price in connection with acquisitions | $355.0K | $0 | $137.0K |
No quarter-by-quarter statement was filed.
Corporate structure
AdaptHealth Corp. sits at the top of its group. 203 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of AdaptHealth Corp.
- REINHART PARTNERS, LLC. Filed SCHEDULE 13G/A on AdaptHealth Corp., latest Oct 13, 2026 (2 filings since May 15, 2025)
- DIMENSIONAL FUND ADVISORS LP Filed SCHEDULE 13G/A on AdaptHealth Corp., latest Oct 8, 2026 (2 filings since Apr 9, 2026)
- VANGUARD GROUP INC Filed SCHEDULE 13G/A on AdaptHealth Corp., latest Mar 26, 2026 (7 filings since Feb 9, 2022)
- Richard M. Cashin Jr. Filed SCHEDULE 13D/A on AdaptHealth Corp., latest Mar 12, 2026
- FMR LLC Filed SCHEDULE 13G/A on AdaptHealth Corp., latest Feb 5, 2026 (5 filings since Feb 9, 2023)
- James E. Flynn Filed SCHEDULE 13G/A on AdaptHealth Corp., latest Nov 13, 2025 (5 filings since Feb 11, 2022)
- BlackRock Filed SCHEDULE 13G/A on AdaptHealth Corp., latest Jul 17, 2025 (6 filings since Sep 8, 2022)
- Pacer Advisors, Inc. Filed SCHEDULE 13G/A on AdaptHealth Corp., latest May 2, 2025 (2 filings since May 2, 2025)
- Jefferies & Company Filed SCHEDULE 13G/A on AdaptHealth Corp., latest Feb 13, 2025 (2 filings since Nov 13, 2024)
- Everest Hill Group Inc. Filed SC 13D/A on AdaptHealth Corp., latest Jun 11, 2024 (3 filings since Nov 7, 2022)
- Peloton Equity AeroCare SPV I, L.P. Filed SC 13D/A on AdaptHealth Corp., latest Aug 11, 2023 (2 filings since May 16, 2023)
- SkyKnight Aero Holdings, LLC Filed SC 13D/A on AdaptHealth Corp., latest Jun 16, 2022
- AdaptHealth Corp. Conshohocken, Pennsylvania
- ABC Medical, LLC Subsidiary · South Carolina, United States
- Absolute Respiratory Care, LLC Subsidiary · Rhode Island, United States
- Access Medical, LLC Subsidiary · Michigan, United States
- Accucare Medical Equipment, LLC Subsidiary · Oklahoma, United States
- ActivStyle Holding Company Subsidiary · Delaware, United States
- AdaptHealth - Missouri LLC Subsidiary · Missouri, United States
- AdaptHealth Holdings LLC Subsidiary · Delaware, United States
- AdaptHealth Intermediate HoldCo LLC Subsidiary · Delaware, United States
- AdaptHealth Minnesota LLC Subsidiary · Minnesota, United States
- AdaptHealth New England LLC Subsidiary · Delaware, United States
- AdaptHealth Patient Care Solutions LLC Subsidiary · Pennsylvania, United States
- AdaptHealth West LLC Subsidiary · Delaware, United States
- Aerocare Home Medical Equipment, Inc. Subsidiary · Texas, United States
- Aerocare Home Medical Equipment, Inc. (MO) Subsidiary · Missouri, United States
- Aerocare Home Medical, Inc. Subsidiary · Texas, United States
- Aerocare, Inc. Subsidiary · Nevada, United States
- Agile Medical LLC Subsidiary · Pennsylvania, United States
- Agilis Med Holdings LLC Subsidiary · Delaware, United States
- AirCare Home Respiratory, LLC Subsidiary · California, United States
- Airway Oxygen, Inc. Subsidiary · Michigan, United States
- All American Oxygen, Inc. Subsidiary · Kentucky, United States
- Ameri-Quipt of North Carolina, Inc. Subsidiary · North Carolina, United States
- America's Health Care at Home, LLC Subsidiary · Delaware, United States
- American Ancillaries, Inc. Subsidiary · Nevada, United States
- American Home Medical, Inc. Subsidiary · Florida, United States
- and 177 more
Built from subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What AdaptHealth Corp. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Operating-lease assets (leased space) | $112.0M5 Dec 31, 2025 | $106.0M5 Dec 31, 2024 | +5.6% |
Intangibles and goodwill
| Item | Latest | A year before | Change |
|---|---|---|---|
| Goodwill | $2.5B5 Dec 31, 2025 | $2.7B5 Dec 31, 2024 | −5.0% |
| Intangible assets, net (excluding goodwill) | $85.1M5 Dec 31, 2025 | $105.5M5 Dec 31, 2024 | −19.4% |
| Finite-lived intangibles, net | $85.1M5 Dec 31, 2025 | $105.5M5 Dec 31, 2024 | −19.4% |
Inventory
Properties, in its own words
We lease all of our offices and facilities. Our corporate headquarters currently consists of approximately 22,600 square feet in an office building located at 555 East North Lane, Suite 5075, Conshohocken, Pennsylvania 19428. In addition to our corporate headquarters, we lease facilities for our operating locations, billing centers, and other warehouse and office space. All facilities are leased pursuant to operating leases. We believe that our facilities are suitable and adequate for our current needs. We review our facility footprint on a regular basis and add locations as needed to support patient growth.
Item 2 of the 10-K filed Feb 24, 2026.4
Leadership
Who has led AdaptHealth Corp., and when. Pick a name to see everywhere that person has worked.
Chief executive
Chief financial officer
Chief operating officer
20202025
- Chief executive officerSuzanne Foster May 20, 2024 to now13
- Chief executive officerStephen P. Griggs Feb 3, 2021 to May 10, 202314
- Chief executive officerLuke McGee Nov 13, 2019 to Feb 12, 202115
- Chief executive officerRichard A. Barasch Feb 15, 2018 to May 9, 202416
- PresidentJosh Parnes Nov 13, 2019 to Feb 7, 202417
- PresidentRichard A. Barasch Feb 15, 2018 to Apr 3, 201816
- Chief financial officerHarriss T. Currie Sep 11, 2026 to now18
- Chief financial officerJason A. Clemens Aug 12, 2020 to Sep 11, 202619
- Chief financial officerGregg A. Holst Nov 13, 2019 to Nov 13, 201920
- Chief financial officerChris Wolfe Feb 15, 2018 to Nov 13, 201921
- Chief operating officerDaniel Edward McFadden May 29, 2026 to now22
- Chief operating officerToby Scott Barnhart Sep 24, 2024 to May 29, 202623
- Chief operating officerDaniel Bunting May 10, 2021 to Mar 2, 202324
- Chief operating officerShaw Rietkerk Mar 5, 2020 to Feb 7, 202425
Board members and other officers (30)
- Chief Business Systems OfficerDaniel Edward McFadden Jun 26, 2025 to now26
- Chief Commercial OfficerRussell E. Schuster Iii. Dec 12, 2024 to now27
- Chief Accounting OfficerChristine E. Archbold Mar 14, 2023 to now28
- Chief Technology OfficerAlbert A. Prast May 10, 2021 to now29
- Chief Accounting OfficerFrank Mullen Oct 1, 2020 to Mar 2, 202230
- Chief Revenue OfficerShaw Rietkerk Nov 13, 2019 to Nov 25, 201931
- Board memberKenneth A. Samet Jun 26, 2026 to now32
- Board memberSuzanne Foster May 20, 2024 to now13
- Board memberDiana L. Nole Oct 28, 2024 to now33
- Board memberStephen P. Griggs Feb 3, 2021 to May 10, 202314
- Board memberCarlos A. Ferrer Feb 4, 2021 to Jun 12, 202434
- Board memberEquity Aerocare Spv L.p. Peloton Ii. Feb 4, 2021 to Dec 13, 202334
- Board memberEquity I. L.p. Peloton Feb 4, 2021 to Dec 13, 202334
- Board memberMatthew Ebbel Feb 4, 2021 to Aug 14, 202335
- Board memberTheodore B. Lundberg Feb 4, 2021 to now36
- Board memberGregory Belinfanti Oct 4, 2021 to now37
- Board memberBradley J. Coppens Jul 17, 2020 to now38
- Board memberAlan G. Quasha Nov 13, 2019 to May 13, 202139
- Board memberDale B. Wolf Nov 13, 2019 to now40
- Board memberJosh Parnes Nov 13, 2019 to Oct 28, 202417
- Board memberLuke McGee Nov 13, 2019 to Feb 12, 202115
- Board memberTerence J. Connors Nov 13, 2019 to now41
- Board memberChristopher J. Joyce Dec 18, 2019 to Dec 18, 201942
- Board memberJames E. Flynn Feb 15, 2018 to Nov 13, 201943
- Board memberMgmt L.p. Deerfield Iv. Feb 15, 2018 to Nov 13, 201943
- Board memberMohit Kaushal Feb 15, 2018 to Nov 13, 201944
- Board memberRichard A. Barasch Feb 15, 2018 to Jun 24, 202416
- Board memberSusan T. Weaver Feb 15, 2018 to now45
- General counselRichard W. Rew Ii. Jan 10, 2025 to now46
- General counselChristopher J. Joyce Nov 13, 2019 to Mar 13, 202347
Subsidiaries and ownership
Subsidiaries (Exhibit 21)
- ABC Medical, LLC SOUTH CAROLINA3
- Absolute Respiratory Care, LLC RHODE ISLAND3
- Access Medical, LLC MICHIGAN3
- Accucare Medical Equipment, LLC OKLAHOMA3
- ActivStyle Holding Company DELAWARE3
- AdaptHealth - Missouri LLC MISSOURI3
- AdaptHealth Holdings LLC DELAWARE3
- AdaptHealth Intermediate HoldCo LLC DELAWARE3
- AdaptHealth LLC DELAWARE3
- AdaptHealth Minnesota LLC MINNESOTA3
- AdaptHealth New England LLC DELAWARE3
- AdaptHealth Patient Care Solutions LLC PENNSYLVANIA3
- AdaptHealth West LLC DELAWARE3
- Aerocare Home Medical Equipment, Inc. TEXAS3
- Aerocare Home Medical Equipment, Inc. (MO) MISSOURI3
- Aerocare Home Medical, Inc. TEXAS3
- Aerocare, Inc. NEVADA3
- Agile Medical LLC PENNSYLVANIA3
- Agilis Med Holdings LLC DELAWARE3
- AirCare Home Respiratory, LLC CALIFORNIA3
- Airway Oxygen, Inc. MICHIGAN3
- All American Oxygen, Inc. KENTUCKY3
- Ameri-Quipt of North Carolina, Inc. NORTH CAROLINA3
- America's Health Care at Home, LLC DELAWARE3
All 206 listed subsidiaries
- American Ancillaries, Inc. NEVADA3
- American Home Medical, Inc. FLORIDA3
- Americoast Maryland LLC DELAWARE3
- Atlantic Medical Supply, Inc. FLORIDA3
- Atlantic Medical, Inc. VIRGINIA3
- Austin Respiratory Equipment, Inc. FLORIDA3
- B-Pharm, Inc. MISSOURI3
- BHS, Inc. KENTUCKY3
- Beacon Respiratory Services of Georgia, Inc. DELAWARE3
- Beacon Respiratory Services, Inc. DELAWARE3
- Bennett Medical Services LLC NEVADA3
- BestMED Respiratory, Inc. IOWA3
- Bird & Bear Medical, Inc. ARKANSAS3
- Blue Dot Medical, LLC MISSISSIPPI3
- Bluegrass Oxygen, Inc. KENTUCKY3
- Braden Partners, L.P. CALIFORNIA3
- Bradley DME LLC TENNESSEE3
- Brannons Rentals and Sales, Inc. CALIFORNIA3
- Breathe Grace Medical Supply, LLC MARYLAND3
- Buffalo Wheelchair, Inc. NEW YORK3
- BuypapUSA.com, Inc. OREGON3
- Cair Respiratory Services LLC MARYLAND3
- Cape Medical Supply, LLC MASSACHUSETTS3
- Care Plus Oxygen, LLC PENNSYLVANIA3
- Carmichaels Home Medical Equipment, Inc. GEORGIA3
- Choice Medical Health Care, LLC ILLINOIS3
- Choice Respiratory & Medical Equipment, Inc. VIRGINIA3
- Clay Home Medical, Inc. VIRGINIA3
- Clearview Medical Incorporated TEXAS3
- Community Medical Supply, Inc. IOWA3
- Community Surgical Supply of Toms River LLC DELAWARE3
- Cornerstone Medical Services -- Midwest, LLC OHIO3
- Cornerstone Medical Services of Columbus, LLC OHIO3
- CressCare Medical, Inc. PENNSYLVANIA3
- DSCM Holdco Inc NEBRASKA3
- Desloge Home Oxygen and Medical Equipment, Inc. FLORIDA3
- Diabetes Management & Supplies LLC LOUISIANA3
- Diabetes Supply Center of the Midlands LLC NEBRASKA3
- Edge Medical Supply, LLC TEXAS3
- Express Medical Supply, LLC TEXAS3
- Family Home Medical Supply LLC PENNSYLVANIA3
- Family Medical Supply LLC NORTH CAROLINA3
- First Choice Home Medical Equipment, LLC DELAWARE3
- First Choice In-HomeCare, Inc. VIRGINIA3
- First Choice Medical Equipment, Inc. ILLINOIS3
- Fletchers Medical Supplies Inc FLORIDA3
- Florida Home Cair, Inc. FLORIDA3
- Florida Home Medical Supply, LLC FLORIDA3
- Freedom Respiratory, Inc. VIRGINIA3
- GME Medical Supply, Inc. VIRGINIA3
- Gammie Homecare Inc. HAWAII3
- Georgia Home Medical - Columbus, Inc. GEORGIA3
- Georgia Home Medical, Inc. GEORGIA3
- Gould’s Discount Medical, LLC KENTUCKY3
- Grace Healthcare Incorporated LOUISIANA3
- Grace Healthcare Medical, Inc. MISSISSIPPI3
- Grace Healthcare, Inc. MISSISSIPPI3
- Grace Medical Equipment, Inc. ALABAMA3
- Grace Medical, Inc. FLORIDA3
- Halprin, Incorporated NEW YORK3
- Health Complex Medical, LLC CONNECTICUT3
- Health Products Plus, Inc. GEORGIA3
- Healthline Medical Equipment, LLC TEXAS3
- Healthy Living Medical Supply, LLC MICHIGAN3
- Heartland Medical Equipment, Inc. MISSOURI3
- Home Care Medical, Inc. WISCONSIN3
- Home Medical Express, Inc. ILLINOIS3
- Home Medical Products and Services LLC WISCONSIN3
- Home Mediservice, LLC MARYLAND3
- Home Nursing Care, Inc. VIRGINIA3
- Home Respiratory Solution's, Inc. FLORIDA3
- Hometown Respiratory Consultants, LLC TENNESSEE3
- Hub's Home Oxygen & Medical Supplies, LLC PENNSYLVANIA3
- Huey’s Home Medical, LLC DELAWARE3
- Hurst Medical Equipment, Inc. WEST VIRGINIA3
- J.M.R. Medical, LLC DELAWARE3
- Keene Medical Products LLC NEW HAMPSHIRE3
- LCP Solara Blocker Corp DELAWARE3
- Lamar, LLC FLORIDA3
- Legacy Medical, LLC OHIO3
- Lehigh Valley Respiratory Care - Lancaster, LLC PENNSYLVANIA3
- LifeHME, Inc. SOUTH CAROLINA3
- Loftis Home Medical, LLC NORTH CAROLINA3
- Lookout Medical Services, Inc. TENNESSEE3
- Louisville O2, Inc. KENTUCKY3
- Lovell Medical Supply, Inc. NORTH CAROLINA3
- MME II, LLC TEXAS3
- Madison County Medical Equipment, Inc. IOWA3
- Major Medical Supply of Brighton, LLC COLORADO3
- Major Medical Supply of Colorado Springs, LLC COLORADO3
- Major Medical Supply of Denver, LLC COLORADO3
- Major Medical Supply of Fort Collins, LLC COLORADO3
- Major Medical Supply of Greeley, LLC COLORADO3
- Major Medical Supply, LLC COLORADO3
- Manor Respiratory Care, Inc. TENNESSEE3
- Matrix Medical, LLC FLORIDA3
- McFarland Group, LLC TENNESSEE3
- Med Star Surgical & Breathing Equipment Inc. NEW YORK3
- Med Way Medical, Inc. UTAH3
- Med-Equip, Inc. PENNSYLVANIA3
- MedBridge Home Medical LLC DELAWARE3
- Medical Logic Ft. Walton, Inc. ALABAMA3
- Medical Logic, Inc. ALABAMA3
- Medical Necessities and Services, LLC TENNESSEE3
- Medidex, LLC MISSOURI3
- Medlogic Anniston, Inc. ALABAMA3
- Medlogic Birmingham, Inc. ALABAMA3
- Medstar Holdings LLC DELAWARE3
- Medway Medical Equipment, LLC TEXAS3
- Mississippi HMA DME, LLC MISSISSIPPI3
- Montgomery Medical Supply, Inc. ALABAMA3
- NRE Holding LLC DELAWARE3
- New England Home Medical Equipment LLC MASSACHUSETTS3
- Northshore Respiratory and Rehab Specialties, Inc. LOUISIANA3
- Ocean Breeze Infusion Care LLC NEW YORK3
- Ocean Home Health Supply LLC NEW JERSEY3
- Ocean Home Health of PA LLC PENNSYLVANIA3
- Ogles Oxygen, LLC SOUTH CAROLINA3
- Olympia Respiratory Services LLC WASHINGTON3
- Ours Corporation ILLINOIS3
- Oxygen & Sleep Associates, Inc. TENNESSEE3
- Oxygen One, Inc. WISCONSIN3
- Oxygen Supply Shop, LLC NEW JERSEY3
- PPS HME Holdings LLC DELAWARE3
- PPS HME LLC DELAWARE3
- PVHS Home Medical Supply, LLC COLORADO3
- Pal-Med, LLC SOUTH CAROLINA3
- Palmetto Oxygen, LLC SOUTH CAROLINA3
- Parrish Home Medical, Inc. SOUTH CAROLINA3
- Peach Home Health Care, Inc. GEORGIA3
- Pharmacy, Inc. DELAWARE3
- Pinnacle Medical Solutions LLC MISSISSIPPI3
- Pinnacle Medical Solutions, Inc. DELAWARE3
- Prattville Medical Equipment, Inc. ALABAMA3
- Premier Home Care, Inc. KENTUCKY3
- Premier Home Medical Equipment Services, LLC PENNSYLVANIA3
- Promise Medical, Inc. TEXAS3
- Provider Plus, LLC MISSOURI3
- Pumps It Inc TEXAS3
- Quality Home Medical, Inc. SOUTH CAROLINA3
- Quality Medical Services, Inc. IOWA3
- Quality Respi-Care, Inc. GEORGIA3
- Reliable Medical Equipment, LLC SOUTH CAROLINA3
- Reliable Medical of Conway, LLC SOUTH CAROLINA3
- Resp-I-Care, LLC TENNESSEE3
- Respiratory Home Care of Bristol, LLC TENNESSEE3
- Respiratory Services of Western New York Inc NEW YORK3
- Respracare, Inc. NORTH CAROLINA3
- Roberts Home Medical, LLC MARYLAND3
- Rocky Mountain Medical Equipment, Inc. COLORADO3
- Rocky Mountain Medical Equipment, LLC COLORADO3
- Royal Homestar LLC DELAWARE3
- Royal Medical Supply LLC NEW JERSEY3
- Skinny, LLC FLORIDA3
- Skoro Enterprises LLC TEXAS3
- Sleep Therapy LLC MINNESOTA3
- SleepEasy Therapeutics, Inc. NORTH DAKOTA3
- Solara Holdings, LLC DELAWARE3
- Solara Intermediate, LLC DELAWARE3
- Solara Medical Supplies, LLC CALIFORNIA3
- Sound Oxygen Service LLC WASHINGTON3
- Southern Home Respiratory & Equipment, Inc. VIRGINIA3
- Specialized Medical Devices, Inc. ALABAMA3
- Spiro Health Services, LLC DELAWARE3
- Sunbelt Medical Supply & Oxygen, Inc. FLORIDA3
- TC Medical Supply, LLC FLORIDA3
- THH Acquisition LLC I DELAWARE3
- TMS VT, LLC VERMONT3
- The 3700 Company, L.L.C. COLORADO3
- Total Homecare LLC VIRGINIA3
- Total Respiratory, LLC DELAWARE3
- TriCounty Medical Equipment and Supply, LLC PENNSYLVANIA3
- Tricorex, Inc. MISSOURI3
- Trinity Healthcare of Winston-Salem, Inc. GEORGIA3
- Twin Rivers Respiratory Care, Inc. ARKANSAS3
- Verio Healthcare, Inc. CALIFORNIA3
- Verus Healthcare Holdings LLC DELAWARE3
- Verus Healthcare LLC DELAWARE3
- Vitacare, L.L.C. OKLAHOMA3
- WeCare Medical Somerset, LLC KENTUCKY3
- WeCare Medical, LLC KENTUCKY3
- Wolf Industries, Inc. MISSISSIPPI3
The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.
Former names
- DFB Healthcare Acquisitions Corp.Dec 29, 2017 to Nov 8, 20192
Timeline
- Sep 8, 20268-K Executive or director change; Regulation FD disclosure48
- Aug 4, 20268-K Results of operations49
- Jul 20, 20268-K Entered a material agreement50
- Jul 7, 20268-K Regulation FD disclosure51
- Jul 2, 20268-K Cybersecurity incident52
- Jun 22, 20268-K Shareholder vote53
- Jun 2, 20268-K Executive or director change54
- May 5, 20268-K Results of operations; Executive or director change55
- Apr 13, 20268-K Entered a material agreement; Ended a material agreement; New debt or obligation56
- Feb 24, 20268-K Results of operations57
- Nov 4, 20258-K Results of operations58
- Aug 5, 20258-K Regulation FD disclosure59
- May 20, 2024New chief executive Suzanne Foster becomes CEO13
- Feb 3, 2021New chief executive Stephen P. Griggs becomes CEO14
- Nov 13, 2019New chief executive Luke McGee becomes CEO15
- Feb 15, 2018New chief executive Richard A. Barasch becomes CEO16
Calendar
Coming up
- Nov 3, 2026Reports results for the quarter ending Sep/202660
When it reported results
- Aug 4, 2026Reported quarterly or annual results49
- May 5, 2026Reported quarterly or annual results55
- Feb 24, 2026Reported quarterly or annual results57
- Nov 4, 2025Reported quarterly or annual results58
- Aug 5, 2025Reported quarterly or annual results61
- May 6, 2025Reported quarterly or annual results62
- Feb 25, 2025Reported quarterly or annual results63
- Nov 5, 2024Reported quarterly or annual results64
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
386 filings to the SEC since October 2021: 6 annual reports, 15 quarterly reports, 59 major events, 221 insider forms, 38 large holders, 47 other. The latest 20:
- Oct 13, 2026SCHEDULE 13G/A EDGAR
- Oct 8, 2026SCHEDULE 13G/A EDGAR
- Sep 11, 20264 OWNERSHIP DOCUMENT EDGAR
- Sep 11, 20263 OWNERSHIP DOCUMENT EDGAR
- Sep 8, 20268-K EDGAR
- Aug 14, 20264/A OWNERSHIP DOCUMENT EDGAR
- Aug 10, 20264 OWNERSHIP DOCUMENT EDGAR
- Aug 10, 20264 OWNERSHIP DOCUMENT EDGAR
- Aug 4, 202610-Q EDGAR
- Aug 4, 20268-K EDGAR
- Jul 20, 20268-K EDGAR
- Jul 7, 20268-K EDGAR
- Jul 6, 20264 OWNERSHIP DOCUMENT EDGAR
- Jul 2, 20268-K EDGAR
- Jul 1, 2026144 EDGAR
- Jun 26, 20264 OWNERSHIP DOCUMENT EDGAR
- Jun 26, 20264 OWNERSHIP DOCUMENT EDGAR
- Jun 26, 20264 OWNERSHIP DOCUMENT EDGAR
- Jun 26, 20264 OWNERSHIP DOCUMENT EDGAR
- Jun 26, 20264 OWNERSHIP DOCUMENT EDGAR
The 386 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
91 open-market trades by officers, directors and large owners since October 2021: 38 buys and 53 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 7, 2026 | WOLF DALE BDirector | Buy | 20,000 | $5.86 | $117.2K | Form 4 |
| Aug 6, 2026 | WOLF DALE BDirector | Buy | 20,000 | $6.30 | $126.0K | Form 4 |
| Aug 6, 2026 | SAMET KENNETH ADirector | Buy | 23,500 | $6.38 | $149.9K | Form 4 |
| Aug 6, 2026 | WOLF DALE BDirector | Buy | 20,000 | $6.37 | $127.4K | Form 4 |
| Jul 1, 2026 | Schuster III Russell E.Chief Commercial Officer | Sale | 11,275 | $10.44 | $117.7K | Form 4 |
| Jun 1, 2026 | Schuster III Russell E.Chief Commercial Officer | Sale | 11,275 | $10.06 | $113.4K | Form 4 |
| Mar 20, 2026 | OEP VII Project A Co-Investment Partners, L.P.10% owner | Buy | 447,100 | $9.91 | $4.4M | Form 4 |
| Mar 20, 2026 | CASHIN RICHARD M JR10% owner | Buy | 447,100 | $9.91 | $4.4M | Form 4 |
| Mar 19, 2026 | OEP VII Project A Co-Investment Partners, L.P.10% owner | Buy | 727 | $9.94 | $7.2K | Form 4 |
| Mar 19, 2026 | CASHIN RICHARD M JR10% owner | Buy | 727 | $9.94 | $7.2K | Form 4 |
| Mar 12, 2026 | OEP VII General Partner, L.P.10% owner | Buy | 689,336 | $9.73 | $6.7M | Form 4 |
| Mar 12, 2026 | CASHIN RICHARD M JR10% owner | Buy | 689,336 | $9.73 | $6.7M | Form 4 |
| Mar 11, 2026 | OEP VII General Partner, L.P.10% owner | Buy | 536,827 | $9.73 | $5.2M | Form 4 |
| Mar 11, 2026 | CASHIN RICHARD M JR10% owner | Buy | 536,827 | $9.73 | $5.2M | Form 4 |
| Mar 10, 2026 | OEP VII General Partner, L.P.10% owner | Buy | 820,528 | $9.73 | $8.0M | Form 4 |
| Mar 10, 2026 | CASHIN RICHARD M JR10% owner | Buy | 820,528 | $9.73 | $8.0M | Form 4 |
| Feb 27, 2026 | WOLF DALE BDirector | Buy | 8,000 | $8.96 | $71.7K | Form 4 |
| Feb 26, 2026 | Rew Richard W. IICLO and General Counsel | Buy | 5,000 | $8.91 | $44.5K | Form 4 |
| Dec 4, 2025 | Williams David Solomon IIIDirector | Sale | 5,000 | $9.43 | $47.1K | Form 4 |
| Aug 22, 2025 | Williams David Solomon IIIDirector | Sale | 8,200 | $9.73 | $79.8K | Form 4 |
All 91 trades can be filtered by person here when JavaScript is on.
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- REINHART PARTNERS, LLC.SCHEDULE 13G/A, 2 filings May 15, 2025 to Oct 13, 202665
- DIMENSIONAL FUND ADVISORS LPSCHEDULE 13G/A, 2 filings Apr 9, 2026 to Oct 8, 202666
- VANGUARD GROUP INCSCHEDULE 13G/A, 7 filings Feb 9, 2022 to Mar 26, 202667
- Richard M. Cashin Jr.SCHEDULE 13D/A, 1 filing Mar 12, 202668
- FMR LLCSCHEDULE 13G/A, 5 filings Feb 9, 2023 to Feb 5, 202669
- James E. FlynnSCHEDULE 13G/A, 5 filings Feb 11, 2022 to Nov 13, 202570
- BlackRockSCHEDULE 13G/A, 6 filings Sep 8, 2022 to Jul 17, 202571
- Pacer Advisors, Inc.SCHEDULE 13G/A, 2 filings May 2, 202572
- Jefferies & CompanySCHEDULE 13G/A, 2 filings Nov 13, 2024 to Feb 13, 202573
- Everest Hill Group Inc.SC 13D/A, 3 filings Nov 7, 2022 to Jun 11, 202474
- Peloton Equity AeroCare SPV I, L.P.SC 13D/A, 2 filings May 16, 2023 to Aug 11, 202375
- SkyKnight Aero Holdings, LLCSC 13D/A, 1 filing Jun 16, 202276
Executive pay
What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.
| Year | Executive | Age | Salary | Total pay |
|---|---|---|---|---|
| 2025 | Suzanne FosterChief Executive Officer | 56 | $1.0M | $10.3M77 |
| 2025 | Jason ClemensChief Financial Officer | 48 | $670.0K | $5.0M77 |
| 2025 | Toby Scott BarnhartChief Operating Officer | 58 | $600.0K | $3.0M77 |
| 2025 | Russell SchusterChief Commercial Officer | 49 | $450.0K | $3.0M77 |
| 2025 | Albert PrastChief Technology Officer | 65 | $450.0K | $2.7M77 |
| 2024 | Suzanne FosterChief Executive Officer | 56 | $561.6K | $8.4M77 |
| 2024 | Jason ClemensChief Financial Officer | 48 | $635.7K | $6.4M77 |
| 2024 | Albert PrastChief Technology Officer | 65 | $453.5K | $2.9M77 |
| 2024 | Toby Scott BarnhartChief Operating Officer | 58 | $166.2K | $1.3M77 |
| 2023 | Jason ClemensChief Financial Officer | 48 | $520.0K | $2.4M77 |
| 2023 | Albert PrastChief Technology Officer | 65 | $450.0K | $1.8M77 |
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| Oep Capital Advisors, L.P. | 16,312,698 | $170.0M | 100.0% | No change |
| BlackRock, Inc. | 16,061,990 | $167.4M | 0.0% | +122,037 |
| Deerfield Management Company, L.P. | 11,477,730 | $119.6M | 1.5% | No change |
| SkyKnight Capital, L.P. | 8,580,443 | $89.4M | 95.0% | No change |
| Fmr LLC | 7,882,906 | $82.1M | 0.0% | −171,785 |
| Dimensional Fund Advisors LP | 7,670,019 | $79.9M | 0.0% | +749,046 |
| Reinhart Partners, Llc. | 7,415,537 | $77.3M | 1.8% | −2,666,446 |
| Vanguard Portfolio Management LLC | 6,426,008 | $67.0M | 0.0% | +320,148 |
| Vanguard Capital Management LLC | 4,843,543 | $50.5M | 0.0% | +345,525 |
| State Street Corp | 4,634,476 | $48.2M | 0.0% | +335,328 |
| Principal Financial Group Inc | 3,305,227 | $34.4M | 0.0% | +520,911 |
| Segall Bryant & Hamill, LLC | 3,219,417 | $33.5M | 0.4% | −259,175 |
| Geode Capital Management, LLC | 2,808,886 | $29.3M | 0.0% | +127,951 |
| Kennedy Capital Management LLC | 2,410,614 | $25.1M | 0.4% | −59,153 |
| Arrowstreet Capital, Limited Partnership | 2,075,423 | $21.6M | 0.0% | +1,228,338 |
| Ameriprise Financial Inc | 2,062,968 | $21.5M | 0.0% | +495,422 |
| Charles Schwab Investment Management Inc | 1,811,646 | $18.9M | 0.0% | −271,283 |
| Invesco Ltd. | 1,571,240 | $16.4M | 0.0% | −68,642 |
| Royal Bank Of Canada | 1,355,676 | $14.1M | 0.0% | −112,316 |
| Northern Trust Corp | 1,324,721 | $13.8M | 0.0% | +94,102 |
| Neuberger Berman Group LLC | 1,130,358 | $11.8M | 0.0% | +300,407 |
| Bastion Asset Management Inc. | 1,148,094 | $11.7M | 4.0% | +592,330 |
| Palisade Capital Management, LP | 1,013,781 | $10.6M | 0.5% | −1,148,900 |
| Bridgeway Capital Management, LLC | 987,761 | $10.3M | 0.2% | −18,543 |
| Morgan Stanley | 986,173 | $10.3M | 0.0% | +139,695 |
13F reports cover disclosed long positions in U.S. stocks only.
Members of Congress who traded it
14 trades disclosed by members of Congress. “Vs S&P since” is the stock’s change since the trade minus the S&P 500’s.
| Date | Member | Trade | Amount | Vs S&P since | Filing |
|---|---|---|---|---|---|
| Apr 6, 2023 | Kevin HernRepublican, House | Sale | $1,001 - $15,000 | +139.1% | Report |
| Apr 6, 2023 | Kevin HernRepublican, House | Sale | $1,001 - $15,000 | +139.1% | Report |
| Nov 30, 2022 | Susie LeeDemocratic, House | Sale | $1,001 - $15,000 | +162.3% | Report |
| Apr 22, 2022 | Kevin HernRepublican, House | Sale | $1,001 - $15,000 | +139.2% | Report |
| Apr 1, 2022 | Kevin HernRepublican, House | Sale | $50,001 - $100,000 | +134.2% | Report |
| Aug 25, 2021 | Kevin HernRepublican, House | Buy | $100,001 - $250,000 | −146.9% | Report |
| May 26, 2021 | Susie LeeDemocratic, House | Buy | $1,001 - $15,000 | −161.9% | Report |
| May 20, 2021 | Kevin HernRepublican, House | Buy | $1,001 - $15,000 | −161.3% | Report |
| May 20, 2021 | Kevin HernRepublican, House | Buy | $1,001 - $15,000 | −161.3% | Report |
| May 20, 2021 | Kevin HernRepublican, House | Buy | $1,001 - $15,000 | −161.3% | Report |
| Feb 11, 2021 | Susie LeeDemocratic, House | Buy | $1,001 - $15,000 | −180.0% | Report |
| Feb 9, 2021 | Susie LeeDemocratic, House | Buy | $1,001 - $15,000 | −181.2% | Report |
| Jan 22, 2021 | Susie LeeDemocratic, House | Buy | $1,001 - $15,000 | −185.7% | Report |
| Jan 5, 2021 | Susie LeeDemocratic, House | Buy | $1,001 - $15,000 | −190.1% | Report |
Members report amounts as ranges, not exact figures. Returns are price-only (no dividends).
SEC filer profile
How AdaptHealth Corp. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARAdaptHealth Corp.1
- CIK0001725255
- Employer ID (EIN)82-36777044
- Filer statusLarge accelerated filer not an emerging growth company; not a smaller reporting company; not a shell company4
- Incorporated inDelaware4
- Fiscal year endsDecember 311
- Industry code (SIC)8082 Services-Home Health Care Services1
- SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
- Business address555 East North Lane, Suite 5075, Conshohocken, PA 194281
- Phone610-424-45151
- Shares outstanding136,344,196 as of Jul 31, 202611
- Public float$1.0B as of Jun 30, 20254
- AuditorKPMG LLP, Philadelphia, Pennsylvania PCAOB ID 185; it also attests to the company’s internal control over financial reporting4
- On EDGAR sinceDec 29, 20171
- Filings733 in all: 4 (289), 8-K (112), 3 (42), 424B3 (32), 10-Q (26), SC 13D/A (26), 144 (24), UPLOAD (18)1
All 40 form types
CORRESP (17), SC 13G/A (15), 4/A (13), SC 13D (10), SCHEDULE 13G/A (10), DEFA14A (9), SC 13G (9), 10-K (8), DEF 14A (8), PRER14A (7), EFFECT (6), S-1/A (6), S-8 (6), 8-K/A (4), ARS (4), SCHEDULE 13G (4), 424B4 (3), PRE 14A (3), S-1 (3), S-3 (3), 10-K/A (2), 25-NSE (2), 424B5 (2), 5 (2), 8-A12B (1), CERT (1), DEFM14A (1), DEFR14A (1), DRS (1), PREM14A (1), S-1MEF (1), SCHEDULE 13D/A (1)
- Latest filingsAnnual report (10-K) Feb 24, 2026
Quarterly report (10-Q) Aug 4, 2026
Proxy statement (DEF 14A) Apr 28, 2026
Latest 8-K (8-K) Sep 8, 2026
Securities registered for trading
| Class | Symbol | Exchange |
|---|---|---|
| Common Stock, par value $0.0001 per share | AHCO | The Nasdaq Stock Market LLC |
From the cover page of the 10-K filed Feb 24, 2026 (Section 12(b) of the Exchange Act).4
Risk factors and legal proceedings
The risks AdaptHealth Corp. names in Item 1A of its 10-K filed Feb 24, 2026: 48 risks under these headings, as written.4
- We operate in a rapidly changing environment that involves a number of risks. The following discussion highlights some of these risks and others are discussed elsewhere in this report. These and other risks could materially adversely affect our business, revenue, financial condition and results of operations. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations.
- Risks Related to Our Business and Industry
- Reliance on relatively few suppliers for the majority of AdaptHealth's patient service equipment and supplies could adversely affect its ability to operate.
- Supply chain disruptions and economy-wide labor shortages in the U.S. have negatively impacted, and may continue to negatively impact, AdaptHealth’s businesses.
- AdaptHealth has been, and may continue to be, negatively impacted by inflation and rising interest rates.
- AdaptHealth’s business depends on its information systems, including software licensed from or hosted by third parties, and any failure or significant disruption or successful cyber-attacks or security breaches on any of these systems, or unauthorized disclosure of or loss of data stored therein could materially affect our business, results of operations and financial condition.
- AdaptHealth’s results of operations may be adversely impacted if expenses under capitated agreements exceed revenues.
- AdaptHealth's financial performance is affected by continuing efforts by private third-party payors to control their costs, and if AdaptHealth agrees to lower its reimbursement rates due to pricing pressures from such private third-party payors, AdaptHealth’s financial condition and results of operations would likely deteriorate.
- AdaptHealth’s payor contracts are subject to renegotiation or termination, which could result in a decrease in AdaptHealth’s revenue or profits.
- Changes made by payors to the way they cover products supplied by AdaptHealth could have an adverse impact on AdaptHealth’s revenue and operations.
- Changes in governmental or private payor supply replenishment schedules could adversely affect AdaptHealth.
- If AdaptHealth fails to manage the complex and lengthy reimbursement process, its revenue, financial condition and results of operations could suffer.
The other 37 risks
- AdaptHealth generates a significant portion of its revenue from the provision of sleep therapy equipment and supplies to patients, and AdaptHealth’s success is therefore highly dependent on its ability to furnish these items.
- AdaptHealth may be adversely affected by consolidation among health insurers and other industry participants.
- AdaptHealth may be adversely affected if it is unable to maintain current levels of collectability, and the deterioration of the financial condition of AdaptHealth’s payors or disputes with third parties could have a significant negative impact on its financial condition and results of operations.
- If AdaptHealth is unable to maintain or develop relationships with patient referral sources, its growth and profitability could be adversely affected.
- AdaptHealth experiences competition from numerous other sleep therapy equipment, home respiratory, mobility equipment and diabetes medical devices and supplies providers, and this competition could adversely affect its revenues and its business.
- Changes in medical equipment technology and development of new treatments may cause AdaptHealth’s current equipment or services to become obsolete.
- The use or anticipated use of artificial intelligence (“AI”) technologies, including generative AI, by us or third parties, could result in reputational harm, competitive harm, and legal liability, and may increase or create new operational risks.
- AdaptHealth’s operations involve the transport of compressed and liquid oxygen, which carries an inherent risk of rupture or other accidents with the potential to cause substantial loss, and have involved the operation of medical gas facilities that are subject to federal and state regulations, which requires significant compliance oversight and expenses.
- AdaptHealth currently outsources, and from time to time in the future may outsource, a portion of its internal business functions to third-party providers, which has significant risks, and AdaptHealth’s failure to manage these risks successfully could materially adversely affect its business, results of operations, and financial condition.
- AdaptHealth's ability to successfully operate its business is largely dependent upon the efforts of key personnel of AdaptHealth, including senior management, the loss of any of whom could negatively impact AdaptHealth's operations and financial results.
- AdaptHealth’s strategic growth plan, which historically involved the acquisition of other companies, may not succeed.
- Political and economic conditions, including significant global or regional developments such as economic and political events, the imposition of tariffs, a prolonged government shutdown, international conflicts (including the ongoing war in Ukraine and conflict in the Middle East), natural disasters and public health crises that are out of AdaptHealth’s control, could adversely affect its revenue, financial condition and results of operations.
- AdaptHealth’s current insurance program is expensive to maintain and may expose it to unexpected costs and negatively affect its business, financial condition and results of operations, particularly if it incurs losses not covered by its insurance or if claims or losses differ from its estimates.
- Risks Related to Regulation
- AdaptHealth’s revenue could be impacted by federal and state changes to reimbursement and other Medicaid and Medicare policies.
- AdaptHealth is subject to United States federal and state healthcare fraud and abuse and false claims laws and regulations, the prosecutions under which have increased in recent years and AdaptHealth may become subject to such litigation, and if AdaptHealth is unable to comply or has not fully complied with such laws, it could face substantial penalties.
- Failure by AdaptHealth to successfully design, modify and implement technology-based and other process changes to maximize productivity and ensure compliance could ultimately have a significant negative impact on AdaptHealth’s financial condition, reputation and results of operations.
- If CMS requires prior authorization or implements changes in documentation necessary for AdaptHealth’s products, AdaptHealth’s revenue, financial condition and results of operations could be negatively impacted.
- If CMS pursued payment reductions to Medicare’s payment rates for CGMs and supplies or takes other actions recommended by the OIG-HHS in its November 2025 report regarding CGMs, AdaptHealth’s revenue, financial condition and results of operations could be negatively impacted.
- Reimbursement claims are subject to audits by various governmental and private payor entities from time to time and such audits may negatively affect AdaptHealth’s revenue, financial condition and results of operations.
- Significant reimbursement reductions and/or exclusion from markets or product lines could adversely affect AdaptHealth.
- Failure by AdaptHealth to maintain required licenses and accreditation could impact its operations.
- Actual or perceived failures to comply with applicable data protection, privacy and security, and consumer protection laws, regulations, standards and other requirements could adversely affect AdaptHealth's business, results of operations and financial condition.
- AdaptHealth may be adversely affected by global climate change or by legal, regulatory or market responses to such change.
- Risks Related to Our Financial Condition
- If AdaptHealth were required to write down all or part of its goodwill, its net earnings and net worth could be materially adversely affected.
- AdaptHealth may not be able to generate sufficient cash flow to cover required payments or comply with financial and operating covenants under its long-term debt and long-term operating leases.
- AdaptHealth may need additional capital to fund its operating subsidiaries and finance its growth, and AdaptHealth may not be able to obtain it on acceptable terms, or at all, which may limit its ability to grow.
- AdaptHealth’s only significant asset is its ownership of AdaptHealth Holdings, and such ownership may not be sufficient to generate the funds necessary to meet its financial obligations or to pay any dividends on its Common Stock.
- Risks Related to Our Securities
- We may not be able to effectively maintain controls and procedures required by Section 404 of the Sarbanes-Oxley Act that are applicable to us or remediate material weaknesses.
- Fluctuations in the price of AdaptHealth’s securities could contribute to the loss of all or part of your investment.
- The timing and amount of AdaptHealth’s share repurchases are subject to a number of uncertainties that could negatively impact the value of AdaptHealth’s shares and its liquidity.
- Certain of AdaptHealth's principal stockholders have significant influence over us.
- Because AdaptHealth has no current plans to pay cash dividends on its Common Stock for the foreseeable future, you may not receive any return on investment unless you sell your Common Stock for a price greater than that which you paid for it.
- We are required to make payments under the Tax Receivable Agreement for certain tax benefits we may claim, and the amounts of such payments could be significant.
- In certain cases, payments under the Tax Receivable Agreement may be accelerated and/or significantly exceed the actual benefits, if any, we realize in respect of the tax attributes subject to the Tax Receivable Agreement.
- We will not be reimbursed for any payments made to TRA Holders under the Tax Receivable Agreement in the event that any tax benefits are disallowed.
- The interests of the TRA Holders in our business may conflict with the interests of our stockholders.
- AdaptHealth's Charter requires that the Court of Chancery of the State of Delaware and, to the extent enforceable, the federal district courts of the United States of America be the exclusive forums for substantially all disputes between AdaptHealth and its stockholders, which may have the effect of discouraging lawsuits against AdaptHealth's directors and officers.
Legal proceedings
From time to time and in the normal course of business, the Company is involved in legal proceedings relating to its business. While there can be no assurance, based on the Company’s evaluation of information currently available, the Company’s management, following consultation with legal counsel, does not expect the ultimate disposition of any or a combination of any such legal proceedings to have a material adverse effect on our business, financial condition or operating results. However, the Company’s assessment may change in the future based upon availability of new information and further developments in such legal proceedings. The results of legal proceedings are inherently uncertain, and material adverse outcomes are possible. Regardless of the outcome of any particular legal proceedings and the merits of any particular claim, litigation can have a material adverse impact on the Company due to, among other reasons, any injunctive relief granted which could inhibit the Company’s ability to operate its business, amounts paid as damages or in settlement of any such matter, diversion of management resources and defense costs. See Note 18, Commitments and Contingencies, and Item 7. “Management's Discussion and Analysis of Financial Results and Operations - Commitments and Contingencies," in this report for information concerning other potential contingent liabilities matters that do not rise to the level of materiality for purposes of disclosure hereunder.
The opening of Item 3, Legal Proceedings.4
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15SEC EDGARLuke McGee, Chief executive officer
- 16
- 17SEC EDGARJosh Parnes, President
- 18
- 19
- 20
- 21SEC EDGARChris Wolfe, Chief financial officer
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31SEC EDGARShaw Rietkerk, Chief Revenue Officer
- 32SEC EDGARKenneth A. Samet, Board member
- 33SEC EDGARDiana L. Nole, Board member
- 34SEC EDGARCarlos A. Ferrer, Board member
- 35SEC EDGARMatthew Ebbel, Board member
- 36SEC EDGARTheodore B. Lundberg, Board member
- 37SEC EDGARGregory Belinfanti, Board member
- 38SEC EDGARBradley J. Coppens, Board member
- 39SEC EDGARAlan G. Quasha, Board member
- 40SEC EDGARDale B. Wolf, Board member
- 41SEC EDGARTerence J. Connors, Board member
- 42SEC EDGARChristopher J. Joyce, Board member
- 43SEC EDGARJames E. Flynn, Board member
- 44SEC EDGARMohit Kaushal, Board member
- 45SEC EDGARSusan T. Weaver, Board member
- 46SEC EDGARRichard W. Rew Ii., General counsel
- 47
- 48
- 49SEC EDGARResults of operations
- 50SEC EDGAREntered a material agreement
- 51SEC EDGARRegulation FD disclosure
- 52SEC EDGARCybersecurity incident
- 53SEC EDGARShareholder vote
- 54SEC EDGARExecutive or director change
- 55
- 56
- 57SEC EDGARResults of operations
- 58SEC EDGARResults of operations
- 59SEC EDGARRegulation FD disclosure
- 60NasdaqNasdaq calendar
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77